tradingkey.logo

KORU Medical Systems Inc

KRMD
6.230USD
-0.250-3.86%
收盤 12/26, 16:00美東報價延遲15分鐘
288.41M總市值
虧損本益比TTM

KORU Medical Systems Inc

6.230
-0.250-3.86%

關於 KORU Medical Systems Inc 公司

KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

KORU Medical Systems Inc簡介

公司代碼KRMD
公司名稱KORU Medical Systems Inc
上市日期Oct 27, 1993
CEOTharby (Linda M)
員工數量80
證券類型Ordinary Share
年結日Oct 27
公司地址100 Corporate Drive
城市MAHWAH
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編07430
電話18454692042
網址https://www.korumedical.com/
公司代碼KRMD
上市日期Oct 27, 1993
CEOTharby (Linda M)

KORU Medical Systems Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.12M
+1.41%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
--
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
91.52K
+4.47%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
88.89K
+4.61%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
88.53K
+4.63%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+116.54%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
41.69K
+10.37%
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
名稱
名稱/職務
職務
持股
持股變動
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.12M
+1.41%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
--
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
91.52K
+4.47%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
88.89K
+4.61%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
88.53K
+4.63%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+116.54%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
業務USD
名稱
營收
佔比
Domestic Core
7.10M
69.62%
International Core
2.18M
21.38%
Novel Therapies
917.40K
9.00%
地區USD
名稱
營收
佔比
Domestic
8.01M
78.59%
International
2.18M
21.41%
業務
地區
業務USD
名稱
營收
佔比
Domestic Core
7.10M
69.62%
International Core
2.18M
21.38%
Novel Therapies
917.40K
9.00%

股東統計

更新時間: 11月20日 週四
更新時間: 11月20日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Horton Capital Management LLC
12.68%
First Light Asset Management, LLC
9.77%
Topline Capital Management, LLC
7.88%
The Vanguard Group, Inc.
4.63%
Tharby (Linda M)
4.58%
其他
60.47%
持股股東
持股股東
佔比
Horton Capital Management LLC
12.68%
First Light Asset Management, LLC
9.77%
Topline Capital Management, LLC
7.88%
The Vanguard Group, Inc.
4.63%
Tharby (Linda M)
4.58%
其他
60.47%
股東類型
持股股東
佔比
Hedge Fund
22.21%
Investment Advisor/Hedge Fund
17.73%
Investment Advisor
15.79%
Individual Investor
8.38%
Pension Fund
0.84%
Research Firm
0.33%
Bank and Trust
0.10%
Insurance Company
0.03%
其他
34.58%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
175
25.43M
54.99%
-237.14K
2025Q2
181
28.37M
61.38%
+1.59M
2025Q1
185
26.98M
58.55%
-3.80M
2024Q4
166
28.05M
61.23%
-2.99M
2024Q3
157
26.45M
57.75%
-1.49M
2024Q2
155
27.99M
61.12%
-3.90M
2024Q1
138
29.57M
64.66%
-1.94M
2023Q4
141
31.83M
69.81%
-3.05M
2023Q3
138
32.73M
71.92%
-2.69M
2023Q2
140
33.07M
72.70%
-1.19M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Horton Capital Management LLC
5.87M
12.7%
-16.19K
-0.27%
Apr 02, 2025
First Light Asset Management, LLC
4.68M
10.13%
-32.76K
-0.69%
Jun 30, 2025
Topline Capital Management, LLC
3.61M
7.8%
-212.88K
-5.57%
Jun 30, 2025
The Vanguard Group, Inc.
2.09M
4.51%
+321.66K
+18.23%
Jun 30, 2025
Tharby (Linda M)
2.09M
4.52%
+293.63K
+16.34%
Apr 21, 2025
BlackRock Institutional Trust Company, N.A.
1.67M
3.6%
+1.49M
+818.20%
Jun 30, 2025
Geode Capital Management, L.L.C.
997.15K
2.16%
+501.88K
+101.33%
Jun 30, 2025
Meros Investment Management, LP
850.39K
1.84%
+103.83K
+13.91%
Jun 30, 2025
Acuitas Investments LLC
402.49K
0.87%
+337.28K
+517.17%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
查看更多
iShares Micro-Cap ETF
佔比0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.03%
iShares Russell 2000 ETF
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0%
DFA Dimensional US Sustainability Core 1 ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

KORU Medical Systems Inc的前五大股東是誰?

KORU Medical Systems Inc的前五大股東如下:
Horton Capital Management LLC
持有股份:5.87M
佔總股份比例:12.70%。
First Light Asset Management, LLC
持有股份:4.68M
佔總股份比例:10.13%。
Topline Capital Management, LLC
持有股份:3.61M
佔總股份比例:7.80%。
The Vanguard Group, Inc.
持有股份:2.09M
佔總股份比例:4.51%。
Tharby (Linda M)
持有股份:2.09M
佔總股份比例:4.52%。

KORU Medical Systems Inc的前三大股東類型是什麼?

KORU Medical Systems Inc 的前三大股東類型分別是:
Horton Capital Management LLC
First Light Asset Management, LLC
Topline Capital Management, LLC

有多少機構持有KORU Medical Systems Inc(KRMD)的股份?

截至2025Q3,共有175家機構持有KORU Medical Systems Inc的股份,合計持有的股份價值約為25.43M,占公司總股份的54.99% 。與2025Q2相比,機構持股有所增加,增幅為-6.39%。

哪個業務部門對KORU Medical Systems Inc的收入貢獻最大?

在FY2025Q2,Domestic Core業務部門對KORU Medical Systems Inc的收入貢獻最大,創收7.10M,占總收入的69.62% 。
KeyAI